Literature DB >> 5496073

Hepatic effects of fenzlozic acid.

F D Hart, L S Bain, E C Huskisson, T R Littler, R T Taylor.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1970        PMID： 5496073      PMCID： PMC1010604          DOI： 10.1136/ard.29.6.684

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN： 0003-4967            Impact factor:   19.103


× No keyword cloud information.
  1 in total

1.  Evaluation in man of fenclozic acid (I.C.I. 54,450: Myalex), a new anti-inflamatory agent. II. Clinical trial in patients with rheumatoid arthritis.

Authors:  T M Chalmers; J H Kellgren; D S Platt
Journal:  Ann Rheum Dis       Date:  1969-11       Impact factor: 19.103
  1 in total
  3 in total

1.  An overview of nonsteroidal antiinflammatory agents (NSAIA).

Authors:  W L Norton; M A Meisinger
Journal:  Inflammation       Date:  1977-03       Impact factor: 4.092

2.  Acute liver effects, disposition and metabolic fate of [14C]-fenclozic acid following oral administration to normal and bile-cannulated male C57BL/6J mice.

Authors:  Kathryn Pickup; Scott Martin; Elizabeth A Partridge; Huw B Jones; Jonathan Wills; Tim Schulz-Utermoehl; Alan McCarthy; Alison Rodrigues; Chris Page; Kerry Ratcliffe; Sunil Sarda; Ian D Wilson
Journal:  Arch Toxicol       Date:  2016-11-28       Impact factor: 5.153

3.  The metabolic fate of fenclozic acid in chimeric mice with a humanized liver.

Authors:  Anja Ekdahl; Lars Weidolf; Matthew Baginski; Yoshio Morikawa; Richard A Thompson; Ian D Wilson
Journal:  Arch Toxicol       Date:  2018-08-09       Impact factor: 5.153
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.